Sign up to save your podcasts
Or
Share Pure Global: Singapore's New AI Device Rules - Decoding The Hidden Regulatory Hurdles.
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Pure Global: Singapore's New AI Device Rules - Decoding The Hidden Regulatory Hurdles.
Singapore's Health Sciences Authority (HSA) has just launched a new, more stringent regulatory framework for AI-powered medical devices. This move comes right after the HSA was recognized by the WHO as a world-leading regulatory body, setting a new benchmark for MedTech innovation across Southeast Asia.
This episode breaks down the critical details of this new framework. We explore the new requirements for life-cycle management, data governance, and cybersecurity that are now mandatory for any company looking to launch an AI medical device in Singapore, and what this means for the future of MedTech regulation in the broader ASEAN region.
A common pain point for MedTech innovators is underestimating regulatory shifts. Imagine developing a groundbreaking AI diagnostic tool, only to have your market launch delayed for months because you lack an "Algorithm Change Protocol" that meets the HSA's new, rigorous standards. This is the new reality companies must navigate.
Key questions answered in this episode:
1. What are the three biggest changes in Singapore's new AI medical device regulations?
2. How does the new framework specifically impact software that uses machine learning?
3. What is an "Algorithm Change Protocol" and why is it a game-changer for regulatory submissions?
4. Are there any new cybersecurity requirements that could catch manufacturers by surprise?
5. Why is robust post-market surveillance more critical than ever under these new rules?
6. How might this advanced framework in Singapore influence regulations in neighboring ASEAN countries?
7. What practical steps should startups take now to align their development with these new guidelines?
Navigating the complexities of global MedTech regulations is our specialty. Pure Global offers end-to-end regulatory consulting, combining local expertise with advanced AI tools to streamline your market access. Whether you're a startup or a multinational, we help you get your innovations to market faster. Contact us at [email protected] or visit https://pureglobal.com/ to learn more.
View all episodes
By Ran ChenSingapore's Health Sciences Authority (HSA) has just launched a new, more stringent regulatory framework for AI-powered medical devices. This move comes right after the HSA was recognized by the WHO as a world-leading regulatory body, setting a new benchmark for MedTech innovation across Southeast Asia.
This episode breaks down the critical details of this new framework. We explore the new requirements for life-cycle management, data governance, and cybersecurity that are now mandatory for any company looking to launch an AI medical device in Singapore, and what this means for the future of MedTech regulation in the broader ASEAN region.
A common pain point for MedTech innovators is underestimating regulatory shifts. Imagine developing a groundbreaking AI diagnostic tool, only to have your market launch delayed for months because you lack an "Algorithm Change Protocol" that meets the HSA's new, rigorous standards. This is the new reality companies must navigate.
Key questions answered in this episode:
1. What are the three biggest changes in Singapore's new AI medical device regulations?
2. How does the new framework specifically impact software that uses machine learning?
3. What is an "Algorithm Change Protocol" and why is it a game-changer for regulatory submissions?
4. Are there any new cybersecurity requirements that could catch manufacturers by surprise?
5. Why is robust post-market surveillance more critical than ever under these new rules?
6. How might this advanced framework in Singapore influence regulations in neighboring ASEAN countries?
7. What practical steps should startups take now to align their development with these new guidelines?
Navigating the complexities of global MedTech regulations is our specialty. Pure Global offers end-to-end regulatory consulting, combining local expertise with advanced AI tools to streamline your market access. Whether you're a startup or a multinational, we help you get your innovations to market faster. Contact us at [email protected] or visit https://pureglobal.com/ to learn more.